Prestige Consumer Healthcare (PBH) analyst forecast and price target
Analyst forecast
Consensus of 8 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Buy | $72.00 from $86.00 | May 15, 2026 |
| Oppenheimer | Downgraded | Outperform → Perform | — | May 14, 2026 |
| Oppenheimer | Maintained | Outperform | $65.00 from $77.00 | May 7, 2026 |
| Jefferies | Maintained | Hold | $66.00 from $70.00 | Feb 2, 2026 |
| Canaccord Genuity | Maintained | Buy | $88.00 from $100.00 | Nov 7, 2025 |
| Jefferies | Maintained | Hold | $71.00 from $75.00 | Oct 27, 2025 |
| Oppenheimer | Maintained | Outperform | $72.00 from $82.00 | Oct 21, 2025 |
| Canaccord Genuity | Maintained | Buy | $100.00 from $105.00 | Aug 8, 2025 |
| Scotiabank | Maintained | Sector Perform | $91.00 from $88.00 | May 8, 2025 |
| RBC Capital | Maintained | Sector Perform | $99.00 from $97.00 | May 8, 2025 |
| RBC Capital | Maintained | Sector Perform | $97.00 from $98.00 | May 6, 2025 |
| RBC Capital | Maintained | Sector Perform | $97.00 from $96.00 | Mar 21, 2025 |
| Oppenheimer | Maintained | Outperform | $93.00 from $87.00 | Feb 13, 2025 |
| DA Davidson | Maintained | Buy | $104.00 from $95.00 | Feb 7, 2025 |
| Canaccord Genuity | Maintained | Buy | $100.00 from $93.00 | Feb 7, 2025 |
| Raymond James | Initiated Coverage | Outperform | $100.00 | Dec 19, 2024 |
| DA Davidson | Maintained | Buy | $95.00 | Nov 11, 2024 |
| RBC Capital | Maintained | Sector Perform | $96.00 from $100.00 | Nov 7, 2024 |
| Jefferies | Initiated Coverage | Buy → Hold | $76.00 from $70.00 | Sep 24, 2024 |
| DA Davidson | Maintained | Buy | $95.00 from $93.00 | Aug 28, 2024 |
Frequently asked questions
Is PBH a buy, sell, or hold?
Analysts covering Prestige Consumer Healthcare currently average a Buy rating: 6 buy, 2 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on PBH?
On May 15, 2026, Canaccord Genuity maintained Prestige Consumer Healthcare at Buy with a price target of $72.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.